MedTrace Logo

Colonoscopy Bowel Prep Comparison Among Diabetic Patients

NCT07351019 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-01-20

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if the Golytely or SUPREP bowel preparation works more effectively in bowel cleansing for colorectal cancer screening with colonoscopy in patients with diabetes. The main questions this study aims to answer are:

1. Is there a significant difference in bowel prep cleanse between Golytely and SUPREP in patients with diabetes based on the Boston Bowel Prep Score (BBPS) as assessed by blinded, skilled endoscopists?
2. Is there a significant difference in patients' tolerance between the bowel preparations as assessed by the validated Mayo Bowel Prep Tolerability Form (MBPTF)?

Participants will:

* Be randomized to take either Golytely or SUPREP bowel preparation prior to their colonoscopy
* Complete the MBPTF on the procedure date prior to the scheduled colonoscopy
* Undergo a standardized screening colonoscopy during which time a blinded endoscopist will document the participant's BBPS

The research team hypothesizes that SUPREP will have a significant difference in tolerability (based on MBPTF), while exhibiting no difference in bowel cleanse (based on BBPS) in the diabetic patient population.

Conditions

  • Colon Cancer Screening

Interventions

DRUG

Golytely

Bowel cleanliness and patient tolerability

DRUG

SUPRPEP

Bowel cleanliness and patient tolerability

Sponsors & Collaborators

  • Eisenhower Army Medical Center

    lead FED

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-16
Primary Completion
2026-07-28
Completion
2026-07-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07351019 on ClinicalTrials.gov